FDA Issues Safety Update Involving Yaz/Yasmin

The FDA issued today a safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone.  Both Yaz and Yasmin contain this compound in their pills.  The FDA completed review of two 2011 studies and is continuing to review a separate FDA-funded study evaluating the risk of blood clots in women who used several different types of contraceptives.  The results of this study thusfar do suggest an approximately 1.5 fold increased risk of blood clots for women who used birth control pills containing drospirenone.  That means that women taking Yaz or Yasmin may have a 50% greater risk of developing blood clots than do women taking other types of birth control.  The FDA has scheduled a meeting of Advisory Committees on December 8, 2011 to discuss these issues.  If you are presently on Yaz or Yasmin, you should discuss with your doctor the risks associated with taking these drugs and blood clots.  Likewise, if you are contemplating beginning either of these drugs you should have the same discussion with your physician.  The Taylor Law Firm is representing many women who have been injured by Yaz and Yasmin.  If you would like to discuss your potential claim involving these drugs, please contact us.